Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
2004 1
2005 1
2006 1
2007 3
2008 1
2009 3
2010 2
2011 3
2012 5
2013 3
2014 6
2015 3
2016 9
2017 16
2018 20
2019 16
2020 13
2021 9
2022 11
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36585215

100 results

Results by year

Filters applied: . Clear all
Page 1
Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer.
Gogola S, Rejzer M, Bahmad HF, Alloush F, Omarzai Y, Poppiti R. Gogola S, et al. Cancers (Basel). 2023 Mar 6;15(5):1621. doi: 10.3390/cancers15051621. Cancers (Basel). 2023. PMID: 36900412 Free PMC article. Review.
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial.
Dai B, Zhang S, Wan FN, Wang HK, Zhang JY, Wang QF, Kong YY, Ma XJ, Mo M, Zhu Y, Qin XJ, Lin GW, Ye DW. Dai B, et al. Eur Urol Oncol. 2022 Oct;5(5):519-525. doi: 10.1016/j.euo.2022.06.001. Epub 2022 Jun 29. Eur Urol Oncol. 2022. PMID: 35780048 Clinical Trial.
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
Andruska N, Agabalogun T, Fischer-Valuck BW, Brenneman RJ, Huang Y, Gay HA, Michalski JM, Carmona R, Baumann BC. Andruska N, et al. Brachytherapy. 2022 Sep-Oct;21(5):617-625. doi: 10.1016/j.brachy.2022.04.001. Epub 2022 May 28. Brachytherapy. 2022. PMID: 35641370 Free PMC article.
Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis.
Aydh A, Motlagh RS, Abufaraj M, Mori K, Katayama S, Grossmann N, Rajwa P, Mostafai H, Laukhtina E, Pradere B, Quhal F, Schuettfort VM, Briganti A, Karakiewicz PI, Fajkovic H, Shariat SF. Aydh A, et al. Arab J Urol. 2022 Mar 30;20(2):71-80. doi: 10.1080/2090598X.2022.2026010. eCollection 2022. Arab J Urol. 2022. PMID: 35530569 Free PMC article. Review.
Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables.
Würnschimmel C, Nocera L, Wenzel M, Ruvolo CC, Tian Z, Saad F, Briganti A, Shariat SF, Mirone V, Chun FKH, Tilki D, Graefen M, Karakiewicz PI. Würnschimmel C, et al. J Racial Ethn Health Disparities. 2023 Apr;10(2):708-717. doi: 10.1007/s40615-022-01257-y. Epub 2022 Feb 18. J Racial Ethn Health Disparities. 2023. PMID: 35182370 Free PMC article.
100 results